PETS: PetMed Express, Inc. Stock

SIC 5912 – Drug Stores and Proprietary Stores

Valuation
Market Cap ($M) 76.32
Enterprise Value ($M) 26.23
Book Value ($M) 96.18
Book Value / Share 4.66
Price / Book 0.80
NCAV ($M) 19.77
NCAV / Share 0.96
Price / NCAV 3.86

Profitability (mra)
Return on Invested Capital (ROIC) 0.00
Return on Assets (ROA) 0.00
Return on Equity (ROE) 0.00

Liquidity (mrq)
Quick Ratio 1.18
Current Ratio 1.43

Balance Sheet (mrq) ($M)
Current Assets 68.38
Assets 144.79
Liabilities 48.61
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
05-20 13D Silvercape Investments Ltd 11.10 9.99
02-14 13G/A Hotchkis & Wiley Capital Management Llc 4.70 -10.69
01-31 13G/A Vanguard Group Inc 4.66 -18.11
10-10 13G Nina Capital Holdings Inc.
07-08 13G/A BlackRock, Inc. 2.70 -68.78

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 o TRANSITION REPORT
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 o TRANSITION REPOR
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 o TRANSITION REPORT PUR
2024-06-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 9,383 33,784 27.77
2025-05-29 7,205 32,231 22.35
2025-05-28 9,985 52,036 19.19
2025-05-27 44,209 124,107 35.62

(click for more detail)

Similar Companies
WBA – Walgreens Boots Alliance, Inc.


Financial data and stock pages provided by
Fintel.io

Finpedia: Petmed Express